• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 4C1G20
Device Problem Insufficient Information (3190)
Patient Problems Itching Sensation (1943); Rash (2033)
Event Date 08/28/2022
Event Type  Injury  
Manufacturer Narrative
This is a definitive report.This case was reported from a hospital to chinese authority, and it was forwarded to manufacturer.The reporter did not provide any further information.According to the result of investigation, there were no deviations or out-of-specifications found in the manufacturing process, the in-process testing, the release testing, and the environmental monitoring for lot# 4c1g20.
 
Event Description
On (b)(6) 2022 a female patient of unknown age and weight of 62 kg was given artz dispo injection once a week for maintenance treatment due to "bilateral knee osteoarthropathy" after discharge.After she was discharged from the hospital, she developed a rash all over the body for unknown reasons, itching was unbearable, accompanied by scratches all over the body, so she went to the dermatology outpatient clinic.The doctor asked the patient's medical history and medication history, considering that it was an adverse drug reaction caused by sodium hyaluronate injection, and instructed the patient to stop the drug.On (b)(6) 2022 the patient returned to the outpatient clinic and complained that the rash symptoms were relieved but not cured after the drug was discontinued, and the sodium hyaluronate continued to be used due to the original disease, and the symptoms worsened again, which was more serious than before.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTZ DISPO
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
Manufacturer (Section G)
SEIKAGAKU CORPORATION - TAKAHAGI PLANT
258-5, aza-matsukubo
oaza-akahama
takahagi-shi, ibaraki 318-0 001
JA   318-0001
Manufacturer Contact
pharmacovigilance dept
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0-005
JA   100-0005
MDR Report Key15606852
MDR Text Key301743753
Report Number9612392-2022-00005
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P980044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 09/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Lot Number4C1G20
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/20/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient SexFemale
-
-